Navigation Links
Majority of osteoporosis patients not receiving calcium and vitamin D with treatment
Date:9/15/2008

ome sort of aid, for example, a tool or packaging that would help them take their osteoporosis medication and supplementation. i This need for help is supported by patient preference data, which shows that over 70% of patients believe that providing a bisphosphonate with calcium and vitamin D in one box can help them take their supplements regularly and correctly.

Some European countries are performing better than others

The research highlights interesting differences in attitudes to supplementation across the four European countries. These study results showed that Spain generally proved to be a leader in terms of patient behaviour and knowledge about supplementation. For example, when looking at supplement use, 90% of patients in Spain claimed that they were taking some form of supplementation (calcium alone, vitamin D alone or calcium and vitamin D) with their osteoporosis treatment, compared to as few as 61% in the UK and 69% in France. i Similarly, patients in Spain claimed to discuss supplementation with their physician more regularly than in other countries - 51% compared to 36% in Germany, 24% in France and 9% in the UK.

Patient trends in the UK highlighted areas for improvement. As well as being the lowest users of supplements and one of the least likely to recognise the importance of calcium and vitamin D supplementation, almost a third of UK patients claimed to have never discussed supplementation with their physician. iv

When it came to adhering to supplements, women in France appeared to be the most disciplined out of the four countries, with only 13% claiming to regularly miss a dose of any supplement. This was in contrast to the UK, where almost one in three patients reported regularly missing a supplement dose. i

"The disparities between countries in attitudes to supplementation may be due to differences in cultures, national health policies or local disease awareness initiatives" said Doctor P
'/>"/>

Contact: Nicki Barwise
nicola.barwise@ketchum.com
44-207-611-3885
Ketchum
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Majority of Americans want local action on global warming, says poll
2. ETH Zurich and IBM improve diagnosis of osteoporosis
3. USC School of Dentistry researchers uncover link between osteoporosis drugs and jaw infection
4. Early registrations to global osteoporosis conference
5. New research on structure of bones raises questions for treatment of osteoporosis
6. Hebrew SeniorLife researchers search for aging, osteoporosis genes
7. A home early warning system for cardiac patients
8. New sensory devices will aid Parkinsons and stroke patients
9. Unlocking mystery of why dopamine freezes Parkinsons patients
10. CMV infections affect more than just patients with compromised immune systems, researchers find
11. Smothered genes combine with mutations to yield poor outcome in cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... strengthen the evidence that people who smoke cigarettes over ... for developing colorectal cancer, even after adjusting for other ... not to smoke, or to quit as soon as ... vice president emeritus, epidemiology and surveillance research at the ...
(Date:12/2/2009)... cigarette smoking scenes in movies are more likely ... may be part of the acculturation process associated ... , "Our study supports an R-rating for smoking ... implementation of the World Health Organization Framework Convention ...
(Date:12/2/2009)... Smoky Mountain forest,s woodland herb population has shown that ... recover from logging, according to Purdue University research. , ... 80 years ago, the distribution of trillium plants on ... undisturbed areas. Michael Jenkins, a Purdue assistant professor of ...
Breaking Biology News(10 mins):Cigarette smoking increases colorectal cancer risk 2Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Study finds logging effects vary based on a forest's history, climate 2University of Florida Shands Cancer Center Selects OnCore 28r 29 to Support its Collaborative Research Goals 13034 1University of Florida Shands Cancer Center Selects OnCore 28r 29 to Support its Collaborative Research Goals 13034 2University of Florida Shands Cancer Center Selects OnCore 28r 29 to Support its Collaborative Research Goals 13034 3University of Florida Shands Cancer Center Selects OnCore 28r 29 to Support its Collaborative Research Goals 13034 4University of Florida Shands Cancer Center Selects OnCore 28r 29 to Support its Collaborative Research Goals 13034 5MultiNational Underwriters Is Now HCC Medical Insurance Services 51740 1MultiNational Underwriters Is Now HCC Medical Insurance Services 51740 2 26quot 3BThe Safe 26quot 3B Way To Protect Against The Anguish Of Disaster Recovery 51736 1 26quot 3BThe Safe 26quot 3B Way To Protect Against The Anguish Of Disaster Recovery 51736 2 26quot 3BThe Safe 26quot 3B Way To Protect Against The Anguish Of Disaster Recovery 51736 3
... NY, November 18, 2008 -- Researchers at the University of ... have been used to block and reverse type 1 diabetes ... of the National Academy of Sciences , was led by ... and an expert in the field of autoimmunity. , "The ...
... LAFAYETTE, Ind. - Materials engineers have created a new ... if perfected, might be used for environmental cleanup, water ... last longer than conventional filters for separating oil from ... traits that are usually mutually exclusive. Researchers attached the ...
... German Research Foundation) is intensifying the international ... meeting in Bonn the Grants Committee responsible ... of 13 additional Research Training Groups, 7 ... These enable doctoral researchers to cooperate closely ...
Other Biology News:New filtering technology has environmental, industrial applications 2New filtering technology has environmental, industrial applications 3National and international doctoral training 2National and international doctoral training 3National and international doctoral training 4National and international doctoral training 5National and international doctoral training 6National and international doctoral training 7
(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.com announces ... available in its catalogue: ,, Neurostimulation ... http://www.reportlinker.com/p0164232/Neurostimulation---A-Global-Market-Perspective.html ,, The world ... base of aging population, and the resultant ...
(Date:12/2/2009)... Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: ... a dose confirmation and dosimetry trial of Cotara® in ... of brain cancer. Cotara is a targeted monoclonal ... potential new treatment for GBM. Cotara specifically targets ...
(Date:12/2/2009)... Cell announced today,a feasibility study evaluating the preclinical ... product which combines technology from Weill,Cornell Medical College ... to,treat inherited anemias such as Cooley,s Anemia. , ... a series of technologies to expand, ex vivo,populations ...
(Date:12/2/2009)... The world is going through,extraordinary times; markets are in ... It turns out that the pharma industry has been,relatively ... a,vacation. , During the midst ... & Johnson inaugurated an R&D center in Shanghai, the ...
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
... Dmitriy Ovcharenko, Rich Jarvis, , ... , ... experimental tool for reducing the expression of specific , ... function analysis, target , validation, ...
... Trace amounts of ribonuclease (RNase) , ... ubiquitous in the laboratory environment--on your skin, in the , ... bare hands or on anything left , ... or eliminate RNase contamination. However, determining which , ...
... , ... Cenix Pre-designed siRNAs to Human, Mouse, and Rat , ... Silencer Validated siRNAs , ... Superior siRNA Design Combined with High , Quality Custom RNA ...
Other Biology Technology:Delivering siRNAs to Difficult Cell Types 2Delivering siRNAs to Difficult Cell Types 3Delivering siRNAs to Difficult Cell Types 4Delivering siRNAs to Difficult Cell Types 5Delivering siRNAs to Difficult Cell Types 6Delivering siRNAs to Difficult Cell Types 7Combat RNase Contamination in the Lab 2Combat RNase Contamination in the Lab 3Combat RNase Contamination in the Lab 4Combat RNase Contamination in the Lab 5IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 2IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 3IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 4IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 5IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 6IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 7IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 8IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 9IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 10
One unit is equal to 10Kb (insert DNA + vector). The final cost will increase or decrease according to the final assembled genome size. The price does not include genome annotation....
Nuclear/Cytosol Fractionation Kit Research Focus: other Storage Temperature: 4C Shipping Temperature: 4C...
Peptide-affinity Purified Polyclonal Antibody to MTR...
Polyclonal Antibody to AGAP1 / Centaurin, gamma 2...
Biology Products: